Biogen

About:

Biogen is an American biotechnology company that provides therapeutics for neurological, autoimmune, and rare diseases.

Website: https://www.biogen.com/en_us/home.html

Twitter/X: biogen

Top Investors: JP Morgan

Description:

Biogen Idec uses cutting-edge science to discover, develop, manufacture and market biological products for the treatment of serious diseases with a focus on neurological disorders. Founded in 1978, Biogen Idec is the world's oldest independent biotechnology company. Patients worldwide benefit from its leading multiple sclerosis therapies, and the company generates more than $4 billion in annual revenues.

Total Funding Amount:

$1.5B

Estimated Revenue Range:

$1B to $10B

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

1978-01-01

Founders:

Bernard Mach, Jeff Behrens, Phillip Sharp

Number of Employees:

5001-10000

Last Funding Date:

2023-09-01

IPO Status:

Public

© 2025 bioDAO.ai